首页> 外文会议>IET International Conference on Biomedical Image and Signal Processing >The influence of medication on the oscillatory and dynamic characteristics of subthalamic lacal field potentials in Parkinson's disease
【24h】

The influence of medication on the oscillatory and dynamic characteristics of subthalamic lacal field potentials in Parkinson's disease

机译:药物治疗对帕金森病骨质拉瓦尔场势振荡和动态特征的影响

获取原文

摘要

The dysfunction of subthalamic nucleus is the core to Parkinson's disease. Local field potentials in human subthalamic nucleus contain rich physiological information. The study aimed to quantify the oscillatory and dynamic characteristics of local field potentials of subthalamic nucleus, and their modulation by the medication therapy for Parkinson's disease. The subthalamic nucleus local field potentials were recorded from 17 patients with Parkinson's disease at the states of on and off medication. The oscillatory features were characteristic with the power spectral analysis. Furthermore, the dynamic features were characteristic with time-frequency analysis and the coefficient of variation measure of the time-variant power at each frequency. There was a dominant peak at low beta band (13-19 Hz) with medication off. The medication significantly suppressed the low beta component and increased the theta component (4-6 Hz) (P<;0.001, P<;0.001, t-test). The beta component fluctuated in amplitude and the fluctuation was measured by the coefficient of variation. The coefficient of variation in high beta (22-30Hz) was reduced by medication while it was increased in high gamma band (65-77 Hz). Medication has significant modulation to subthalamic nucleus neural oscillatory synchronization and dynamic features. The subthalamic nucleus neural activities tend towards stable state under medication. The findings would provide quantitative biomarkers for studying the mechanisms of Parkinson's disease and clinical treatments of medication or deep brain stimulation.
机译:亚粒细胞核的功能障碍是帕金森病的核心。人次粒子核中的局部场势含有丰富的生理信息。该研究旨在量化氨基甲核局部场势的振荡和动态特征,及其对帕金森病治疗的调节。氨基甲核核心局部电位从17例帕金森病患者记录在on和OFF药物的状态。振荡特征是具有功率谱分析的特性。此外,动态特征具有时频分析和每个频率时时频功率的变化测量系数的特征。低β带(13-19赫兹)的主要峰值,用药。药物显着抑制了低β组分并增加了θ组分(4-6Hz)(p <; 0.001,p <; 0.001,t检验)。通过变异系数测量幅度和波动的β组件。通过药物减少高β(22-30Hz)的变异系数,而在高γ(65-77Hz)中增加。药物治疗对次粒子核神经振荡同步和动态特征具有显着调节。亚饱和核神经活性趋于在药物下趋于稳定状态。该研究结果将为研究帕金森病和临床治疗的药物或深脑刺激的临床治疗方法提供量化生物标志物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号